Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in OutpatientsByMason W. Russell, MAPE,Douglas C. A. Taylor, MBA,Gordon Cummins, MS,Daniel M. Huse, MAJanuary 1st 2002
Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic EvaluationByDaniel M. Huse, MA,Gordon Cummins, MS,Douglas C. A. Taylor, MBA,Mason W. Russell, MAPEJanuary 1st 2002
Comparison of Rheumatoid Arthritis Care Costs in Patients Starting Therapy with Leflunomide Versus EtanerceptByCyrus Yazdani, MS,Trent McLaughlin, PhD,Gordon Cummins, MS,Joseph Doyle, RPh, MBASeptember 1st 2001
Report: A Descriptive Analysis of the Use and Cost of New-Generation Antihistamines in the Treatment of Allergic Rhinitis: A Retrospective Database AnalysisByJeff Lee, PharmD,Gordon Cummins, MS,Lynn Okamoto, PharmDMay 1st 2001
